MedPath

DOM-IRBESARTAN-HCTZ

DOM-IRBESARTAN-HCTZ

Discontinued
DIN Number

02372231

Drug Class

Human

Market Date

N/A

Company
HC

dominion pharmacal

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02372231
AIG Number0240086002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09DA04 IRBESARTAN AND DIURETICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:32.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

HYDROCHLOROTHIAZIDEActive
Strength: 12.5 MG
Monograph: HYDROCHLOROTHIAZIDE
IRBESARTANActive
Strength: 300 MG
Monograph: IRBESARTAN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.